FRANKLIN RESOURCES INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 165 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$50,396
-41.1%
19,162
-20.9%
0.00%
Q2 2023$85,546
+14.2%
24,2340.0%0.00%
Q1 2023$74,883
-27.0%
24,2340.0%0.00%
Q4 2022$102,510
+79.8%
24,2340.0%0.00%
Q3 2022$57,000
-16.2%
24,234
+1.0%
0.00%
Q2 2022$68,000
-34.0%
23,983
-32.6%
0.00%
Q1 2022$103,000
-99.6%
35,600
-94.3%
0.00%
-100.0%
Q3 2018$28,804,000
-35.1%
628,230
-16.2%
0.01%
-39.1%
Q2 2018$44,353,000
-23.9%
749,845
-12.4%
0.02%
-23.3%
Q1 2018$58,251,000
-29.4%
856,000
+2.6%
0.03%
-25.0%
Q4 2017$82,480,000
-17.2%
834,400
+0.3%
0.04%
-18.4%
Q3 2017$99,572,000
+98.6%
831,500
+45.0%
0.05%
+96.0%
Q2 2017$50,134,000
+117.2%
573,619
+94.8%
0.02%
+108.3%
Q4 2015$23,084,000
-68.1%
294,444
-69.4%
0.01%
-66.7%
Q3 2015$72,421,000
-43.6%
960,999
-12.6%
0.04%
-37.9%
Q2 2015$128,434,000
-49.0%
1,100,076
+3.1%
0.06%
-49.1%
Q1 2015$251,905,000
+180.7%
1,066,904
+125.0%
0.11%
+178.0%
Q4 2014$89,749,000
-28.1%
474,185
-9.4%
0.04%
-28.1%
Q3 2014$124,878,000
+148.0%
523,444
-31.4%
0.06%
+159.1%
Q2 2014$50,360,000
-39.5%
763,034
-4.5%
0.02%
-43.6%
Q1 2014$83,188,000
+29.1%
798,805
+28.4%
0.04%
+25.8%
Q4 2013$64,427,000
+99.5%
622,297
+3.4%
0.03%
+82.4%
Q3 2013$32,298,000
+16.5%
601,897
-3.6%
0.02%
+6.2%
Q2 2013$27,716,000624,6770.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2015
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders